Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide in Mild-to-Moderate Ulcerative Colitis
NCT07820046Phase 3Not yet recruiting
- Sponsor
- Tanta University
- Start
- Jan 2027
- Primary completion
- Jan 2028
01
Overview
A Phase 3 trial of nitazoxanide in ulcerative colitis (UC), sponsored by Tanta University. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
nitazoxanide
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07820046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07820046.